tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Biome Australia Achieves First Net Profit and Significant Revenue Growth in FY25

Story Highlights
Biome Australia Achieves First Net Profit and Significant Revenue Growth in FY25

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Biome Australia Ltd ( (AU:BIO) ) has provided an update.

Biome Australia Limited reported a breakthrough financial year in 2025, achieving its first net profit of $214,656 and a 41.6% increase in sales revenue to $18.4 million. The company saw substantial growth across all key metrics, with international sales rising by 69% and strategic partnerships established in Canada, Ireland, the UK, and New Zealand. Biome’s Activated Probiotics brand became the second-largest in probiotic revenue within community pharmacies, and the company is on track to meet its Vision 27 forecast of $75 million in cumulative sales for FY25-27.

The most recent analyst rating on (AU:BIO) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Biome Australia Ltd stock, see the AU:BIO Stock Forecast page.

More about Biome Australia Ltd

Biome Australia Limited is a microbiome health company that focuses on developing and marketing probiotic products. The company is known for its Activated Probiotics brand, which has secured a strong position in the community pharmacy sector. Biome’s market focus includes domestic and international expansion, with a significant emphasis on customer service, innovative health-targeted products, and clinical backing.

Average Trading Volume: 392,916

Technical Sentiment Signal: Strong Buy

See more data about BIO stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1